AtriCure (ATRC) (AVII) (BBY) (BCSI) (BEN) (BRCM) Ratings, Price Targets

AtriCure (ATRC), AVI BioPharma (AVII), Best Buy Co., Inc. (BBY), Blue Coat (BCSI), Franklin Resources, Inc. (BEN) and Broadcom Corp. (BRCM) ratings and price targets.

Canaccord Genuity reiterated its “Positive” rating on AtriCure (ATRC). They have a price target of $15.50 on the company.

Wedbush lowered its price target on AVI BioPharma (AVII) to $2.50.

TheStreet upgraded Best Buy Co., Inc. (BBY) to a “Buy” rating.

Needham & Company reiterated its “Hold” rating on Blue Coat (BCSI).

JPMorgan Chase & Co. (NYSE:JPM) reiterated its “Underweight” rating on Franklin Resources, Inc. (BEN). They have a price target of $111.00 on the company.

Goldman Sachs (NYSE:GS) reiterated its “Buy” on Broadcom Corp. (BRCM). They have a price target of $41.00 on the company.